These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

455 related items for PubMed ID: 29162724

  • 1. Progesterone receptor A promotes invasiveness and metastasis of luminal breast cancer by suppressing regulation of critical microRNAs by estrogen.
    McFall T, McKnight B, Rosati R, Kim S, Huang Y, Viola-Villegas N, Ratnam M.
    J Biol Chem; 2018 Jan 26; 293(4):1163-1177. PubMed ID: 29162724
    [Abstract] [Full Text] [Related]

  • 2. Clinical association of progesterone receptor isoform A with breast cancer metastasis consistent with its unique mechanistic role in preclinical models.
    Rosati R, Oppat K, Huang Y, Kim S, Ratnam M.
    BMC Cancer; 2020 Jun 03; 20(1):512. PubMed ID: 32493230
    [Abstract] [Full Text] [Related]

  • 3. MicroRNA regulation of progesterone receptor in breast cancer.
    Gilam A, Shai A, Ashkenazi I, Sarid LA, Drobot A, Bickel A, Shomron N.
    Oncotarget; 2017 Apr 18; 8(16):25963-25976. PubMed ID: 28404930
    [Abstract] [Full Text] [Related]

  • 4. Differential expression of the miR-17-92 cluster and miR-17 family in breast cancer according to tumor type; results from the Norwegian Women and Cancer (NOWAC) study.
    Moi L, Braaten T, Al-Shibli K, Lund E, Busund LR.
    J Transl Med; 2019 Oct 03; 17(1):334. PubMed ID: 31581940
    [Abstract] [Full Text] [Related]

  • 5. Role of the short isoform of the progesterone receptor in breast cancer cell invasiveness at estrogen and progesterone levels in the pre- and post-menopausal ranges.
    McFall T, Patki M, Rosati R, Ratnam M.
    Oncotarget; 2015 Oct 20; 6(32):33146-64. PubMed ID: 26356672
    [Abstract] [Full Text] [Related]

  • 6. Expression of Estrogen Receptor- and Progesterone Receptor-Regulating MicroRNAs in Breast Cancer.
    Kalinina T, Kononchuk V, Alekseenok E, Obukhova D, Sidorov S, Strunkin D, Gulyaeva L.
    Genes (Basel); 2021 Apr 16; 12(4):. PubMed ID: 33923732
    [Abstract] [Full Text] [Related]

  • 7. Meta-microRNA Biomarker Signatures to Classify Breast Cancer Subtypes.
    Oztemur Islakoglu Y, Noyan S, Aydos A, Gur Dedeoglu B.
    OMICS; 2018 Nov 16; 22(11):709-716. PubMed ID: 30388053
    [Abstract] [Full Text] [Related]

  • 8. Molecular pathogenesis of breast cancer: impact of miR-99a-5p and miR-99a-3p regulation on oncogenic genes.
    Shinden Y, Hirashima T, Nohata N, Toda H, Okada R, Asai S, Tanaka T, Hozaka Y, Ohtsuka T, Kijima Y, Seki N.
    J Hum Genet; 2021 May 16; 66(5):519-534. PubMed ID: 33177704
    [Abstract] [Full Text] [Related]

  • 9. miRNA-30 Family Members Inhibit Breast Cancer Invasion, Osteomimicry, and Bone Destruction by Directly Targeting Multiple Bone Metastasis-Associated Genes.
    Croset M, Pantano F, Kan CWS, Bonnelye E, Descotes F, Alix-Panabières C, Lecellier CH, Bachelier R, Allioli N, Hong SS, Bartkowiak K, Pantel K, Clézardin P.
    Cancer Res; 2018 Sep 15; 78(18):5259-5273. PubMed ID: 30042152
    [Abstract] [Full Text] [Related]

  • 10. Identification and validation of oncologic miRNA biomarkers for luminal A-like breast cancer.
    McDermott AM, Miller N, Wall D, Martyn LM, Ball G, Sweeney KJ, Kerin MJ.
    PLoS One; 2014 Sep 15; 9(1):e87032. PubMed ID: 24498016
    [Abstract] [Full Text] [Related]

  • 11. MEL-18 loss mediates estrogen receptor-α downregulation and hormone independence.
    Lee JY, Won HY, Park JH, Kim HY, Choi HJ, Shin DH, Kang JH, Woo JK, Oh SH, Son T, Choi JW, Kim S, Kim HY, Yi K, Jang KS, Oh YH, Kong G.
    J Clin Invest; 2015 May 15; 125(5):1801-14. PubMed ID: 25822021
    [Abstract] [Full Text] [Related]

  • 12. MiR-519d-3p suppresses breast cancer cell growth and motility via targeting LIM domain kinase 1.
    Li D, Song H, Wu T, Xie D, Hu J, Zhao J, Shen Q, Fang L.
    Mol Cell Biochem; 2018 Jul 15; 444(1-2):169-178. PubMed ID: 29188531
    [Abstract] [Full Text] [Related]

  • 13. MicroRNA signatures predict oestrogen receptor, progesterone receptor and HER2/neu receptor status in breast cancer.
    Lowery AJ, Miller N, Devaney A, McNeill RE, Davoren PA, Lemetre C, Benes V, Schmidt S, Blake J, Ball G, Kerin MJ.
    Breast Cancer Res; 2009 Jul 15; 11(3):R27. PubMed ID: 19432961
    [Abstract] [Full Text] [Related]

  • 14. miRNA expression in breast cancer varies with lymph node metastasis and other clinicopathologic features.
    Wang B, Li J, Sun M, Sun L, Zhang X.
    IUBMB Life; 2014 May 15; 66(5):371-7. PubMed ID: 24846313
    [Abstract] [Full Text] [Related]

  • 15. TIMP-3 mRNA expression levels positively correlates with levels of miR-21 in in situ BC and negatively in PR positive invasive BC.
    Petrovic N, Sami A, Martinovic J, Zaric M, Nakashidze I, Lukic S, Jovanovic-Cupic S.
    Pathol Res Pract; 2017 Oct 15; 213(10):1264-1270. PubMed ID: 28935174
    [Abstract] [Full Text] [Related]

  • 16. Overexpression of microRNA-200c predicts poor outcome in patients with PR-negative breast cancer.
    Tuomarila M, Luostari K, Soini Y, Kataja V, Kosma VM, Mannermaa A.
    PLoS One; 2014 Oct 15; 9(10):e109508. PubMed ID: 25329395
    [Abstract] [Full Text] [Related]

  • 17. Luminal breast cancer metastases and tumor arousal from dormancy are promoted by direct actions of estradiol and progesterone on the malignant cells.
    Ogba N, Manning NG, Bliesner BS, Ambler SK, Haughian JM, Pinto MP, Jedlicka P, Joensuu K, Heikkilä P, Horwitz KB.
    Breast Cancer Res; 2014 Dec 05; 16(6):489. PubMed ID: 25475897
    [Abstract] [Full Text] [Related]

  • 18. miR-125a-3p inhibits ERα transactivation and overrides tamoxifen resistance by targeting CDK3 in estrogen receptor-positive breast cancer.
    Zheng L, Meng X, Li X, Zhang Y, Li C, Xiang C, Xing Y, Xia Y, Xi T.
    FASEB J; 2018 Feb 05; 32(2):588-600. PubMed ID: 28939591
    [Abstract] [Full Text] [Related]

  • 19. MiR-301a-3p Suppresses Estrogen Signaling by Directly Inhibiting ESR1 in ERα Positive Breast Cancer.
    Lettlova S, Brynychova V, Blecha J, Vrana D, Vondrusova M, Soucek P, Truksa J.
    Cell Physiol Biochem; 2018 Feb 05; 46(6):2601-2615. PubMed ID: 29763890
    [Abstract] [Full Text] [Related]

  • 20. Essential role of MED1 in the transcriptional regulation of ER-dependent oncogenic miRNAs in breast cancer.
    Nagpal N, Sharma S, Maji S, Durante G, Ferracin M, Thakur JK, Kulshreshtha R.
    Sci Rep; 2018 Aug 07; 8(1):11805. PubMed ID: 30087366
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.